Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. - Investor Relations & Filings

Listed IPO Aug 2017
Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 522 across all filing types
Latest filing 2026-07-07 Regulatory Filings
Country PL Poland
Listing WAR SCP · 3 venues

Key figures FY2024

Period ended 2024-12-31 · PLN
Headline annual figures for Scope Fluidics S.A., fiscal year 2024, reported in PLN, with the source filing for each figure.
Total Revenues PLN 119.61M per the Annual Report (ESEF) filed 2025-04-28
Net Income PLN 65.42M per the Annual Report (ESEF) filed 2025-04-28
Total Assets PLN 172.87M per the Annual Report (ESEF) filed 2025-04-28
Total Equity PLN 146.35M per the Annual Report (ESEF) filed 2025-04-28
Cash from Ops PLN -25.10M per the Annual Report (ESEF) filed 2025-04-28

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Zawarcie przez Bacteromic umowy z dystrybutorem - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a corporate announcement regarding the signing of a distribution agreement between a subsidiary (Bacteromic) and a third-party distributor (Biomedica). It describes the scope, territory, and duration of the commercial contract. Since this is a general corporate announcement regarding business operations that does not fit into specific categories like M&A (which usually involves takeovers or mergers) or financial reporting, it falls under the general regulatory announcement category.
2026-07-07 Polish
Podpisanie umowy na przeprowadzenie badań klinicznych Panelu PBC systemu BACTEROMIC - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1147 characters) regarding the signing of a clinical trial agreement for the BACTEROMIC system. It references previous current reports and provides an update on operational progress and regulatory certification timelines. It does not contain full financial statements or audit reports, nor does it fit into specific categories like M&A or share issues. As a general corporate update regarding business operations and regulatory milestones, it falls under the fallback category for regulatory announcements.
2026-07-01 Polish
Aktualizacja informacji nt. półautomatycznej linii produkcyjnej paneli systemu BACTEROMIC - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1201 characters) from Scope Fluidics S.A. regarding the operational status and location of a production line for the BACTEROMIC system. It references a previous current report (17/2026) and provides a business update on production capacity and timelines. As it is a general corporate announcement regarding operational developments that does not fit into specific categories like financial results, M&A, or director dealings, it falls under the general regulatory announcement category.
2026-06-30 Polish
Aktualizacja terminu realizacji pierwszego celu w projekcie HYBOLIC - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement (raport bieżący) from Scope Fluidics S.A. regarding an update on the timeline for a specific project milestone (HYBOLIC). It does not contain financial statements, nor is it an earnings release, annual report, or any other specific category. As it is a general regulatory update regarding company operations and project timelines, it falls under the fallback category for regulatory announcements.
2026-06-26 Polish
Przyznanie patentu spółce Bacteromic przez Urząd Patentów i Znaków Towarowych Stanów Zjednoczonych - Content (PL)
Regulatory Filings Classification · 90% confidence The document is a brief corporate announcement informing stakeholders that the U.S. Patent and Trademark Office has granted a patent to an affiliate. It contains no financial statements, management changes, earnings data, or other specific categories. This type of general regulatory or compliance announcement falls under the fallback category for miscellaneous filings: Regulatory Filings (RNS).
2026-05-27 Polish
Uzyskanie certyfikatu CE-IVDR dla systemu BACTEROMIC z Panelem UNI FAST - Content (PL)
Regulatory Filings Classification · 85% confidence The document is a short current report (“raport bieżący”) in Polish notifying the market about the receipt of a CE-IVDR certificate for the company’s diagnostic system. It contains no financial statements, management changes, or voting results—it is a routine regulatory disclosure. It does not present the full report itself but is an official filing under the market disclosure regime. Therefore, it best fits the Regulatory Filings category.
2026-05-22 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.